Ensuring a high-quality and resilient supply chain of essential medications means paying more.
Where this comes from
- Record sourced from PubMed, PMID 35471068.
- Also identified by DOI 10.18553/jmcp.2022.28.5.573 and PMC identifier 10372977.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>DISCLOSURES:</b> Dr Mattingly reports consulting fees from Arnold Ventures, Pharmaceutical Research and Manufacturers of America, and research support from the US Food and Drug Administration unrelated to this article.
Medical subject headings
- Commerce
- Drug Costs